Response Biomedical Corp (RBM) Financial Statements (2024 and earlier)

Company Profile

Business Address 1781 - 75TH AVENUE W.
VANCOUVER, BC V6P6P2
State of Incorp. BC
Fiscal Year End December 31
Industry (SIC) 8734 - Testing Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,5801,0212,5112,8781,5861,439
Cash and cash equivalents1,5801,0212,5112,8781,5861,439
Receivables5217105665572,0151,872
Inventory, net of allowances, customer advances and progress billings2,1952,1421,8192,1022,7252,499
Inventory2,1952,1421,8192,1022,7252,499
Deferred costs   90576677
Other undisclosed current assets667109134145167301
Total current assets:4,9633,9825,1205,7396,5596,188
Noncurrent Assets
Property, plant and equipment5,3305,5735,6895,9076,1516,392
Prepaid expense939393939393
Restricted cash and investments317317901901901901
Deferred costs   391830
Total noncurrent assets:5,7405,9836,6866,9107,1637,416
TOTAL ASSETS:10,7039,96511,80612,64913,72213,604
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,9623,7553,4663,8385,2804,834
Accounts payable3,7933,5863,2973,6695,1114,665
Accrued liabilities169169169169169169
Debt748814868840783796
Derivative instruments and hedges, liabilities9647423014541,3441,194
Deferred revenue and credits1,5301921,3111,5888671,083
Other undisclosed current liabilities515481489468448428
Total current liabilities:7,7195,9846,4357,1888,7228,335
Noncurrent Liabilities
Long-term debt and lease obligation, including:4,4154,5564,6944,8284,9585,085
Long-term debt, excluding current maturities4,415136360555706910
Other undisclosed long-term debt and lease obligation  4,4204,3344,2734,2524,175
Other undisclosed noncurrent liabilities9431,1211,3881,6251,8182,064
Total noncurrent liabilities:5,3585,6776,0826,4536,7767,149
Total liabilities:13,07711,66112,51713,64115,49815,484
Equity
Equity, attributable to parent(2,374)(1,696)(711)(992)(1,776)(1,880)
Common stock105,010104,314104,314104,314104,314104,270
Additional paid in capital15,59615,64915,38415,32615,27115,209
Accumulated deficit(122,980)(121,659)(120,409)(120,632)(121,361)(121,359)
Total equity:(2,374)(1,696)(711)(992)(1,776)(1,880)
TOTAL LIABILITIES AND EQUITY:10,7039,96511,80612,64913,72213,604

Income Statement (P&L) ($ in thousands)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
Revenues
(Revenue, Net)
1,3212,2044,0843,5284,2663,540
Cost of revenue
(Cost of Goods and Services Sold)
(799)(1,177)(1,424)(1,491)(2,167)(2,243)
Other undisclosed gross profit   (196)684767
Gross profit:5221,0272,4642,1052,1461,364
Operating expenses(1,439)(1,819)(1,996)(1,875)(1,771)(2,152)
Operating income (loss):(917)(792)468230375(788)
Nonoperating income (expense)(405)(458)(920)714(152)(77)
Investment income, nonoperating(223)(441) 892(148)58
Gain (loss), foreign currency transaction, before tax(3)202 (166)(21)(113)
Other nonoperating income (expense)(2)(28) (12)17(22)
Interest and debt expense(177)(191)(203)(215)(225)(235)
Income (loss) from continuing operations:(1,499)(1,441)(655)729(2)(1,100)
Income (loss) before gain (loss) on sale of properties:(1,499)(1,441)(655)729(2)(1,100)
Net income (loss):(1,499)(1,441)(655)729(2)(1,100)
Other undisclosed net income attributable to parent177191878   
Net income (loss) available to common stockholders, diluted:(1,322)(1,250)223729(2)(1,100)

Comprehensive Income ($ in thousands)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
Net income (loss):(1,499)(1,441)(655)729(2)(1,100)
Comprehensive income (loss), net of tax, attributable to parent:(1,499)(1,441)(655)729(2)(1,100)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: